# Effectiveness of Topical Magnetite Zinc Oxide Composite Nanoparticles in the Management of Oral Potentially Malignant Lesions

> **NCT06271564** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 24 (actual)

## Conditions studied

- Oral Potentially Malignant Lesions

## Interventions

- **DRUG:** Magnetite ZnO Composite Nanoparticles
- **DRUG:** Topical Placebo Gel

## Key facts

- **NCT ID:** NCT06271564
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-29
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-04-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06271564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06271564, "Effectiveness of Topical Magnetite Zinc Oxide Composite Nanoparticles in the Management of Oral Potentially Malignant Lesions". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06271564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*